Incannex Healthcare Limited Common Stock
IXHL
6 hedge funds and large institutions have $804K invested in Incannex Healthcare Limited Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.17% more ownership
Funds ownership: 0% → 0.17% (+0.17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$520K |
| 2 |
Morgan Stanley
New York
|
+$276K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$165K |
| 4 |
Old Mission Capital
Chicago,
Illinois
|
+$137K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$38K |
Top Sellers
IXHL Hedge Fund Activity: Q1 2022 in Review
6 of the 6,364 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare Limited Common Stock (IXHL) for Q1 2022, worth a combined $804K.
Buyers outnumbered sellers: 6 funds opened new IXHL positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $520K.
- 6 institutional investors held Incannex Healthcare Limited Common Stock (IXHL) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $804K of Incannex Healthcare Limited Common Stock stock for Q1 2022.
- 6 funds opened new Incannex Healthcare Limited Common Stock positions in Q1 2022 and 0 closed out, a net change of +6 holders.
- The largest Incannex Healthcare Limited Common Stock buyer in Q1 2022 was Jane Street, an estimated $520K added.
Based on aggregated 13F filings for Q1 2022.